Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
First Hawaiian announces up to $75M stock repurchase program » 08:06
02/08/21
02/08
08:06
02/08/21
08:06
FHB

First Hawaiian

$24.63 /

+0.07 (+0.29%)

First Hawaiian announced…

First Hawaiian announced that the Company's Board of Directors has adopted a stock repurchase program for up to $75M of its outstanding common stock during 2021.

ShowHide Related Items >><<
FHB First Hawaiian
$24.63 /

+0.07 (+0.29%)

11/19/20 JPMorgan
First Hawaiian price target raised to $18.50 from $15.50 at JPMorgan
07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
FHB First Hawaiian
$24.63 /

+0.07 (+0.29%)

Over a month ago
Earnings
First Hawaiian reports Q4 core EPS 50c, consensus 44c » 07:05
01/22/21
01/22
07:05
01/22/21
07:05
FHB

First Hawaiian

$25.46 /

-0.48 (-1.85%)

Total stockholders'…

Total stockholders' equity was $2.7B at both December 31, 2020 and September 30, 2020. The tier 1 leverage, common equity tier 1 and total capital ratios were 8.00%, 12.47% and 13.72%, respectively, at December 31, 2020, compared with 7.91%, 12.22% and 13.47%, respectively, at September 30, 2020. "We finished 2020 with a strong quarter and continued to support our customers and meet their evolving needs by leveraging technology, digital channels and our deep relationships," said Bob Harrison, Chairman, President and CEO. "In these uncertain times, our ability to remain agile and innovative positions us well to continue supporting our customers and the community."

ShowHide Related Items >><<
FHB First Hawaiian
$25.46 /

-0.48 (-1.85%)

FHB First Hawaiian
$25.46 /

-0.48 (-1.85%)

11/19/20 JPMorgan
First Hawaiian price target raised to $18.50 from $15.50 at JPMorgan
07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
FHB First Hawaiian
$25.46 /

-0.48 (-1.85%)

Over a quarter ago
Recommendations
First Hawaiian price target raised to $18.50 from $15.50 at JPMorgan » 08:17
11/19/20
11/19
08:17
11/19/20
08:17
FHB

First Hawaiian

$22.03 /

-0.48 (-2.13%)

JPMorgan analyst Steven…

JPMorgan analyst Steven Alexopoulos raised the firm's price target on First Hawaiian to $18.50 from $15.50 and keeps an Underweight rating on the shares after hosting meetings with management.

ShowHide Related Items >><<
FHB First Hawaiian
$22.03 /

-0.48 (-2.13%)

FHB First Hawaiian
$22.03 /

-0.48 (-2.13%)

07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
FHB First Hawaiian
$22.03 /

-0.48 (-2.13%)

FHB First Hawaiian
$22.03 /

-0.48 (-2.13%)

Earnings
First Hawaiian reports Q3 EPS 50c, consensus 28c » 08:08
10/23/20
10/23
08:08
10/23/20
08:08
FHB

First Hawaiian

$16.78 /

+0.64 (+3.97%)

The tier 1 leverage,…

The tier 1 leverage, common equity tier 1 and total capital ratios were 7.91%, 12.22% and 13.47%, respectively, at September 30, 2020, compared with 7.75%, 11.86% and 13.11%, respectively, at June 30, 2020. "In spite of the current economic environment, we reported solid financial results for the third quarter," said Bob Harrison, Chairman, President and CEO. "These are still challenging times, but the re-opening of the local economy, and more recently, the pre-testing program for trans-Pacific travel, are important steps toward the state's economic recovery."

ShowHide Related Items >><<
FHB First Hawaiian
$16.78 /

+0.64 (+3.97%)

FHB First Hawaiian
$16.78 /

+0.64 (+3.97%)

07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
FHB First Hawaiian
$16.78 /

+0.64 (+3.97%)

FHB First Hawaiian
$16.78 /

+0.64 (+3.97%)

Earnings
First Hawaiian reports Q2 EPS 15c, consensus 22c » 08:01
07/24/20
07/24
08:01
07/24/20
08:01
FHB

First Hawaiian

$18.61 /

+0.64 (+3.56%)

The tier 1 leverage,…

The tier 1 leverage, common equity tier 1 and total capital ratios were 7.75%, 11.86% and 13.11%, respectively, at June 30, 2020, compared with 8.63%, 11.65% and 12.90%, respectively, at March 31, 2020. "I am very proud of our teams' extraordinary efforts to manage through the pandemic's disruption with agility and resilience while ensuring the health and safety of their co-workers, customers and community," said Bob Harrison, Chairman, President and CEO. "During this difficult time for our local economy, we focused our efforts on creating stability by offering relief assistance to customers and support to the community. Our teams leveraged technology investments to develop an online application portal that enabled us to secure over $940 million in PPP loans for 6,000 small business customers. We also successfully launched the Aloha for Hawaii Fund, which supported the restaurant industry, and donated $1 million to non-profits for COVID-19 relief. Another $1 million was donated to the Stronger Together Fund to support the 2020 public high school graduates as they transition to the next phase of their lives."

ShowHide Related Items >><<
FHB First Hawaiian
$18.61 /

+0.64 (+3.56%)

FHB First Hawaiian
$18.61 /

+0.64 (+3.56%)

07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
FHB First Hawaiian
$18.61 /

+0.64 (+3.56%)

FHB First Hawaiian
$18.61 /

+0.64 (+3.56%)

Hot Stocks
First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24  04:55
07/24/20
07/24
04:55
07/24/20
04:55
FHB

First Hawaiian

$18.61 /

+0.64 (+3.56%)

, EBS

Emergent BioSolutions

$89.01 /

-4.99 (-5.31%)

 
ShowHide Related Items >><<
FHB First Hawaiian
$18.61 /

+0.64 (+3.56%)

EBS Emergent BioSolutions
$89.01 /

-4.99 (-5.31%)

FHB First Hawaiian
$18.61 /

+0.64 (+3.56%)

07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
EBS Emergent BioSolutions
$89.01 /

-4.99 (-5.31%)

07/17/20 Cantor Fitzgerald
Emergent BioSolutions price target raised to $110 from $85 at Cantor Fitzgerald
07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 Raymond James
Vaxart already had vaccine deals with Emergent, Kindred, notes Raymond James
06/08/20 Guggenheim
Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim
FHB First Hawaiian
$18.61 /

+0.64 (+3.56%)

EBS Emergent BioSolutions
$89.01 /

-4.99 (-5.31%)

FHB First Hawaiian
$18.61 /

+0.64 (+3.56%)

EBS Emergent BioSolutions
$89.01 /

-4.99 (-5.31%)

On The Fly
Fly Intel: After-Hours Movers » 18:49
07/20/20
07/20
18:49
07/20/20
18:49
TBK

Triumph Bancorp

$23.31 /

-0.75 (-3.12%)

, IBM

IBM

$126.42 /

+1.275 (+1.02%)

, CDNS

Cadence Design

$103.85 /

+3.62 (+3.61%)

, FBK

FB Financial

$22.75 /

-0.83 (-3.52%)

, NBEV

NewAge

$1.75 /

+0.075 (+4.49%)

, HIBB

Hibbett Sports

$22.53 /

-0.745 (-3.20%)

, PBIB

Ticker changed to LMST

$0.00 /

+ (+0.00%)

, XENE

Xenon Pharmaceuticals

$12.80 /

+0.61 (+5.00%)

, FHB

First Hawaiian

$15.57 /

-0.295 (-1.86%)

, HSTO

Histogen

$3.11 /

-0.02 (-0.64%)

, CCK

Crown Holdings

$69.63 /

+1.375 (+2.01%)

, ACAD

Acadia

$55.47 /

+0.535 (+0.97%)

, PIRS

Pieris Pharmaceuticals

$3.27 /

+0.01 (+0.31%)

, CTSO

CytoSorbents

$11.51 /

+0.19 (+1.68%)

, KNSA

Kiniksa

$23.92 /

+0.61 (+2.62%)

Check out this evening's…

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$12.80 /

+0.61 (+5.00%)

TBK Triumph Bancorp
$23.31 /

-0.75 (-3.12%)

PIRS Pieris Pharmaceuticals
$3.27 /

+0.01 (+0.31%)

NBEV NewAge
$1.75 /

+0.075 (+4.49%)

KNSA Kiniksa
$23.92 /

+0.61 (+2.62%)

IBM IBM
$126.42 /

+1.275 (+1.02%)

HSTO Histogen
$3.11 /

-0.02 (-0.64%)

HIBB Hibbett Sports
$22.53 /

-0.745 (-3.20%)

FHB First Hawaiian
$15.57 /

-0.295 (-1.86%)

FBK FB Financial
$22.75 /

-0.83 (-3.52%)

CTSO CytoSorbents
$11.51 /

+0.19 (+1.68%)

CDNS Cadence Design
$103.85 /

+3.62 (+3.61%)

CCK Crown Holdings
$69.63 /

+1.375 (+2.01%)

ACAD Acadia
$55.47 /

+0.535 (+0.97%)

TBK Triumph Bancorp
$23.31 /

-0.75 (-3.12%)

07/10/20
Fly Intel: Top five analyst upgrades
07/10/20 DA Davidson
Triumph Bancorp upgraded to Buy from Neutral at DA Davidson
07/10/20 DA Davidson
Triumph Bancorp upgraded to Buy from Neutral at DA Davidson
06/02/20 Wells Fargo
Triumph Bancorp downgraded to Underweight at Wells Fargo on valuation
IBM IBM
$126.42 /

+1.275 (+1.02%)

07/08/20 Stifel
IBM consensus for second half, 2021 appears 'reasonable,' says Stifel
06/09/20 DA Davidson
DA Davidson says Cloudera sale 'increasingly likely,' IBM seen as possible buyer
04/21/20 Morgan Stanley
Krishna years away from returning IBM to sustainable growth, says Morgan Stanley
04/21/20 Wedbush
IBM price target lowered to $140 from $155 at Wedbush
CDNS Cadence Design
$103.85 /

+3.62 (+3.61%)

07/16/20 DA Davidson
Cadence Design price target raised to $115 from $90 at DA Davidson
07/14/20 Wells Fargo
Cadence Design price target raised to $110 from $100 at Wells Fargo
06/15/20 RBC Capital
Cadence Design price target raised to $101 from $85 at RBC Capital
05/28/20 Wells Fargo
Cadence Design price target raised to $100 from $87 at Wells Fargo
FBK FB Financial
$22.75 /

-0.83 (-3.52%)

01/02/20 Truist
SunTrust raises price targets on select regional banks on improved margins
12/09/19 Sandler O'Neill
FB Financial downgraded to Hold from Buy at Sandler O'Neill
10/23/19 Raymond James
FB Financial downgraded to Market Perform on valuation at Raymond James
10/23/19 Raymond James
FB Financial downgraded to Market Perform from Outperform at Raymond James
NBEV NewAge
$1.75 /

+0.075 (+4.49%)

04/14/20 Alliance Global Partners
New Age Beverages at Alliance Global Partners
03/11/20 Compass Point
New Age Beverages price target lowered to $4 from $9 at Compass Point
07/22/19 Northland
Northland downgrades New Age Beverages on 'more realistic' estimates
07/22/19 Northland
New Age Beverages downgraded to Market Perform from Outperform at Northland
HIBB Hibbett Sports
$22.53 /

-0.745 (-3.20%)

07/10/20 Susquehanna
Hibbett Sports price target raised to $30 from $25 at Susquehanna
07/10/20 Susquehanna
Foot Locker upgraded to Positive from Neutral at Susquehanna
07/02/20
Fly Intel: Top five analyst upgrades
07/02/20 BofA
BofA double upgrades Hibbett Sports on COVID market share gains
PBIB Ticker changed to LMST
$0.00 /

+ (+0.00%)

XENE Xenon Pharmaceuticals
$12.80 /

+0.61 (+5.00%)

07/20/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
06/01/20
Fly Intel: Top five analyst initiations
05/31/20 Jefferies
Xenon Pharmaceuticals assumed with a Buy at Jefferies
03/25/20
Fly Intel: Top five analyst initiations
FHB First Hawaiian
$15.57 /

-0.295 (-1.86%)

07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
HSTO Histogen
$3.11 /

-0.02 (-0.64%)

CCK Crown Holdings
$69.63 /

+1.375 (+2.01%)

07/15/20 Jefferies
Canpack's new Scranton plant 'modest negative' for Ball, Crown, says Jefferies
07/15/20 Citi
Can-Pack entry to U.S. would be negative for Ball, Crown, says Citi
07/13/20 Jefferies
Ball Corp. assumed with a Hold at Jefferies
07/13/20 Jefferies
Crown Holdings assumed with a Buy at Jefferies
ACAD Acadia
$55.47 /

+0.535 (+0.97%)

07/16/20 JPMorgan
JPMorgan boosts Acadia target to $66, likes setup into depression data
07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
07/09/20 RBC Capital
Acadia price target raised to $61 from $58 at RBC Capital
07/07/20
Fly Intel: Top five analyst upgrades
PIRS Pieris Pharmaceuticals
$3.27 /

+0.01 (+0.31%)

03/13/20 Baird
Baird upgrades Pieris Pharmaceuticals as pipeline updates expected
03/13/20 Baird
Pieris Pharmaceuticals upgraded to Outperform from Neutral at Baird
03/12/20 H.C. Wainwright
Increased visibility in 2020 expected for Pieris, says H.C. Wainwright
01/27/20 H.C. Wainwright
Pieris Pharmaceuticals price target raised to $9 from $7 at H.C. Wainwright
CTSO CytoSorbents
$11.51 /

+0.19 (+1.68%)

06/02/20 B. Riley Securities
CytoSorbents gaining relevance as COVID-19 treatment, says B. Riley FBR
05/14/20 B. Riley Securities
CytoSorbents label expansion could significantly expand use, says B. Riley FBR
05/06/20 B. Riley Securities
B. Riley boosts CytoSorbents target, says Portola deal highlights value
03/25/20 Dawson James
CytoSorbents being used for COVID-19 in Italy, China, says Dawson James
KNSA Kiniksa
$23.92 /

+0.61 (+2.62%)

07/17/20 JPMorgan
Kiniksa risk/reward attractive into Phase 2 data, says JPMorgan
06/29/20 Goldman Sachs
Kiniksa price target raised to $33 from $29 at Goldman Sachs
06/29/20 Wedbush
Kiniksa price target raised to $38 from $30 at Wedbush
04/01/20
Fly Intel: Top five analyst initiations
XENE Xenon Pharmaceuticals
$12.80 /

+0.61 (+5.00%)

TBK Triumph Bancorp
$23.31 /

-0.75 (-3.12%)

PIRS Pieris Pharmaceuticals
$3.27 /

+0.01 (+0.31%)

NBEV NewAge
$1.75 /

+0.075 (+4.49%)

KNSA Kiniksa
$23.92 /

+0.61 (+2.62%)

IBM IBM
$126.42 /

+1.275 (+1.02%)

HIBB Hibbett Sports
$22.53 /

-0.745 (-3.20%)

FHB First Hawaiian
$15.57 /

-0.295 (-1.86%)

FBK FB Financial
$22.75 /

-0.83 (-3.52%)

CTSO CytoSorbents
$11.51 /

+0.19 (+1.68%)

CDNS Cadence Design
$103.85 /

+3.62 (+3.61%)

CCK Crown Holdings
$69.63 /

+1.375 (+2.01%)

ACAD Acadia
$55.47 /

+0.535 (+0.97%)

  • 22
    Jul
  • 22
    Jul
  • 14
    May
  • 22
    Jan
  • 18
    Sep
NBEV NewAge
$1.75 /

+0.075 (+4.49%)

IBM IBM
$126.42 /

+1.275 (+1.02%)

HIBB Hibbett Sports
$22.53 /

-0.745 (-3.20%)

CTSO CytoSorbents
$11.51 /

+0.19 (+1.68%)

CCK Crown Holdings
$69.63 /

+1.375 (+2.01%)

NBEV NewAge
$1.75 /

+0.075 (+4.49%)

KNSA Kiniksa
$23.92 /

+0.61 (+2.62%)

IBM IBM
$126.42 /

+1.275 (+1.02%)

HIBB Hibbett Sports
$22.53 /

-0.745 (-3.20%)

CTSO CytoSorbents
$11.51 /

+0.19 (+1.68%)

CCK Crown Holdings
$69.63 /

+1.375 (+2.01%)

ACAD Acadia
$55.47 /

+0.535 (+0.97%)

IBM IBM
$126.42 /

+1.275 (+1.02%)

HSTO Histogen
$3.11 /

-0.02 (-0.64%)

FBK FB Financial
$22.75 /

-0.83 (-3.52%)

CDNS Cadence Design
$103.85 /

+3.62 (+3.61%)

Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices » 17:41
07/20/20
07/20
17:41
07/20/20
17:41
EBS

Emergent BioSolutions

$102.04 /

-2.1 (-2.02%)

, CZR

Caesars

$12.39 /

-0.02 (-0.16%)

, ERI

Eldorado Resorts

$38.18 /

+0.18 (+0.47%)

, FHB

First Hawaiian

$15.57 /

-0.295 (-1.86%)

Emergent BioSolutions…

Emergent BioSolutions (EBS) will replace Caesars Entertainment (CZR) in the S&P MidCap 400, and First Hawaiian (FHB) will replace Emergent BioSolutions in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 24. S&P MidCap 400 constituent Eldorado Resorts (ERI) acquired Caesars Entertainment in a deal completed July 20. Post-merger, Eldorado Resorts will change its name to Caesars Entertainment and its ticker to CZR. It will remain in the S&P MidCap 400.

ShowHide Related Items >><<
FHB First Hawaiian
$15.57 /

-0.295 (-1.86%)

ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

EBS Emergent BioSolutions
$102.04 /

-2.1 (-2.02%)

CZR Caesars
$12.39 /

-0.02 (-0.16%)

EBS Emergent BioSolutions
$102.04 /

-2.1 (-2.02%)

07/17/20 Cantor Fitzgerald
Emergent BioSolutions price target raised to $110 from $85 at Cantor Fitzgerald
07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 Raymond James
Vaxart already had vaccine deals with Emergent, Kindred, notes Raymond James
06/08/20 Guggenheim
Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim
CZR Caesars
$12.39 /

-0.02 (-0.16%)

07/08/20 Jefferies
Eldorado Resorts price target raised to $51 from $38 at Jefferies
06/29/20 Stifel
Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon
06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
06/02/20 Nomura
Eldorado Resorts price target raised to $34 from $12.50 at Nomura Instinet
ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

06/12/20 Truist
SunTrust raises price target on select Gaming names amid positive room-rate data
FHB First Hawaiian
$15.57 /

-0.295 (-1.86%)

07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
FHB First Hawaiian
$15.57 /

-0.295 (-1.86%)

ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

EBS Emergent BioSolutions
$102.04 /

-2.1 (-2.02%)

CZR Caesars
$12.39 /

-0.02 (-0.16%)

  • 17
    Jun
ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

CZR Caesars
$12.39 /

-0.02 (-0.16%)

ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

EBS Emergent BioSolutions
$102.04 /

-2.1 (-2.02%)

CZR Caesars
$12.39 /

-0.02 (-0.16%)

ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

CZR Caesars
$12.39 /

-0.02 (-0.16%)

Hot Stocks
First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24  17:19
07/20/20
07/20
17:19
07/20/20
17:19
FHB

First Hawaiian

$15.57 /

-0.295 (-1.86%)

, EBS

Emergent BioSolutions

$102.04 /

-2.1 (-2.02%)

 
ShowHide Related Items >><<
FHB First Hawaiian
$15.57 /

-0.295 (-1.86%)

EBS Emergent BioSolutions
$102.04 /

-2.1 (-2.02%)

FHB First Hawaiian
$15.57 /

-0.295 (-1.86%)

07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
EBS Emergent BioSolutions
$102.04 /

-2.1 (-2.02%)

07/17/20 Cantor Fitzgerald
Emergent BioSolutions price target raised to $110 from $85 at Cantor Fitzgerald
07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 Raymond James
Vaxart already had vaccine deals with Emergent, Kindred, notes Raymond James
06/08/20 Guggenheim
Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim
FHB First Hawaiian
$15.57 /

-0.295 (-1.86%)

EBS Emergent BioSolutions
$102.04 /

-2.1 (-2.02%)

EBS Emergent BioSolutions
$102.04 /

-2.1 (-2.02%)

Downgrade
Fly Intel: Top five analyst downgrades » 10:03
07/07/20
07/07
10:03
07/07/20
10:03
KMI

Kinder Morgan

$14.74 /

-0.46 (-3.03%)

, CZZ

Cosan

$17.68 /

-0.15 (-0.84%)

, D

Dominion

$72.55 /

-1.045 (-1.42%)

, FHB

First Hawaiian

$16.08 /

-0.66 (-3.94%)

, YETI

Yeti

$43.00 /

-0.09 (-0.21%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kinder Morgan (KMI) downgraded to Sell from Neutral at Goldman Sachs with analyst Michael Lapides citing the stock's valuation and expects shares to lag large-cap midstream peers in the second half of 2020. 2. Cosan (CZZ) downgraded to Neutral from Overweight at JPMorgan with analyst Lucas Ferreira citing valuation. 3. Dominion (D) was downgraded to Neutral from Outperform at Credit Suisse and to Underperform from Neutral at Mizuho. 4. First Hawaiian (FHB) downgraded to Underweight from Equal Weight at Wells Fargo with analyst Jared Shaw saying the reality of the Hawaiian economy, among the hardest hit in the U.S. with a recovery expected to be the slowest, doesn't "square" with the current 30% TBV premium valuation. 5. Yeti (YETI) downgraded to Neutral from Buy at Goldman Sachs with analyst Alexandra Walvis saying the company's "strong" brand momentum and growth opportunity is now better understood by investors and reflected in the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
YETI Yeti
$43.00 /

-0.09 (-0.21%)

KMI Kinder Morgan
$14.74 /

-0.46 (-3.03%)

FHB First Hawaiian
$16.08 /

-0.66 (-3.94%)

D Dominion
$72.55 /

-1.045 (-1.42%)

CZZ Cosan
$17.68 /

-0.15 (-0.84%)

KMI Kinder Morgan
$14.74 /

-0.46 (-3.03%)

07/06/20 Goldman Sachs
Kinder Morgan downgraded to Sell from Neutral at Goldman Sachs
05/18/20 BofA
Plains All American, GP Holdings cut to Underperform at BofA
04/07/20 Mizuho
Kinder Morgan price target lowered to $20 from $23 at Mizuho
03/24/20 Barclays
Kinder Morgan upgraded to Overweight from Equal Weight at Barclays
CZZ Cosan
$17.68 /

-0.15 (-0.84%)

07/07/20 JPMorgan
Cosan downgraded to Neutral from Overweight at JPMorgan
05/27/20 HSBC
Cosan downgraded to Hold from Buy at HSBC
05/20/20 Goldman Sachs
Cosan downgraded to Neutral from Buy at Goldman Sachs
11/05/19 Bradesco BBI
Cosan downgraded to Neutral from Outperform at Bradesco
D Dominion
$72.55 /

-1.045 (-1.42%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
07/07/20 Mizuho
Dominion downgraded to Underperform from Neutral at Mizuho
07/07/20 Credit Suisse
Dominion downgraded to Neutral from Outperform at Credit Suisse
07/06/20 Wells Fargo
Wells says merits of Dominion's 'forward-looking' deal to be clearer with time
FHB First Hawaiian
$16.08 /

-0.66 (-3.94%)

07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
06/29/20 UBS
First Hawaiian downgraded to Sell from Neutral at UBS
YETI Yeti
$43.00 /

-0.09 (-0.21%)

07/07/20 Goldman Sachs
Yeti downgraded to Neutral from Buy at Goldman Sachs
06/23/20 Piper Sandler
Yeti price target raised to $47 from $35 at Piper Sandler
06/10/20 Cowen
Yeti price target raised to $41 from $31 at Cowen
06/09/20 BTIG
Yeti price target raised to $44 from $36 at BTIG
YETI Yeti
$43.00 /

-0.09 (-0.21%)

KMI Kinder Morgan
$14.74 /

-0.46 (-3.03%)

FHB First Hawaiian
$16.08 /

-0.66 (-3.94%)

D Dominion
$72.55 /

-1.045 (-1.42%)

  • 28
    May
  • 11
    May
  • 17
    Feb
  • 07
    Nov
YETI Yeti
$43.00 /

-0.09 (-0.21%)

KMI Kinder Morgan
$14.74 /

-0.46 (-3.03%)

D Dominion
$72.55 /

-1.045 (-1.42%)

YETI Yeti
$43.00 /

-0.09 (-0.21%)

KMI Kinder Morgan
$14.74 /

-0.46 (-3.03%)

D Dominion
$72.55 /

-1.045 (-1.42%)

KMI Kinder Morgan
$14.74 /

-0.46 (-3.03%)

D Dominion
$72.55 /

-1.045 (-1.42%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.